TFRI and MOHCCN hosted an open-access webinar to outline the application process for the TFRI–MOHCCN Technology Development Awards and to answer any questions.

You can view the presentation here or watch the webinar recording by clicking the link below.

Purpose 

This co-funding opportunity from the Terry Fox Research Institute (TFRI) and the Marathon of Hope Cancer Centres Network (MOHCCN) aims to support the development of proof-of-principle or proof-of-feasibility data for additional profiling approaches to be used in future developments for the MOHCCN. These projects will support existing or new precision cancer research using the MOHCCN model with significant potential for impact on outcomes for patients.   

Scope of the Program 

Projects may involve, but are not limited to, the following topics: 

• Proteomics and protein-based technologies  

• Metabolomics   

• Liquid biopsies and longitudinal samples for assessment of metastasis or heterogeneity  

• Flow Cytometry, CyTOF, Imaging mass spectrometry.  

Applications should detail the technology, evidence of its use in the applicant’s labs, plan for standardization, reproducibility (at more than one site), and data processing/export. Applicants must have appropriate access to samples (include letters to demonstrate consent for sample analysis and access for sharing, as appropriate) and must detail the number of samples to be included in the project (minimum 20).  

Support Offered 

Funding will be available for the remaining two (2) years of the MOHCCN project, Fiscal Years 2024–25 and 2025–26. Projects may apply for up to $250,000 (total amount; delivered over one or two years, depending on project scope). Applicants must demonstrate the ability to begin work in August 2024, have appropriate access to samples and to complete work within the timeframes.